Analysis of Gastrointestinal Toxicity in Patients Receiving Proton Beam Therapy for Prostate Cancer: A Single-Institution Experience
Sign Up to like & getrecommendations! Published in 2019 at "Advances in Radiation Oncology"
DOI: 10.1016/j.adro.2018.08.002
Abstract: Purpose We characterized both physician- and patient-reported rates of gastrointestinal (GI) toxicity in patients treated with proton beam therapy (PBT) at our institution for prostate adenocarcinoma and identified factors associated with toxicity. Methods and materials… read more here.
Keywords: prostate; gastrointestinal toxicity; toxicity patients; toxicity ... See more keywords
Financial Toxicity in Patients with Resected Lung Cancer.
Sign Up to like & getrecommendations! Published in 2023 at "Annals of surgery"
DOI: 10.1158/1538-7445.am2023-726
Abstract: OBJECTIVES We aimed to describe financial toxicity (FT) in patients with resected lung cancer and identify risk factors in this population. SUMMARY BACKGROUND FT describes the financial burden associated with cancer care and its impact… read more here.
Keywords: lung cancer; financial toxicity; resected lung; patients resected ... See more keywords
Risk Associated with Severe Hematological Toxicity in Patients with Urothelial Cancer Receiving Combination Chemotherapy of Gemcitabine and Cisplatin
Sign Up to like & getrecommendations! Published in 2020 at "Chemotherapy"
DOI: 10.1159/000508805
Abstract: Introduction: Combination chemotherapy of gemcitabine and cisplatin (GC) is the standard treatment for patients with urothelial cancer (UC). However, hematological toxicity is a major side effect of GC therapy in patients with UC. In particular,… read more here.
Keywords: chemotherapy; toxicity patients; risk factors; hematological toxicity ... See more keywords
Mass Cytometry Identifies T Cell Populations Associated with Severe Hepatotoxicity in CLL Patients on Upfront Idelalisib
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-118734
Abstract: Introduction Phosphatidylinositol-3-kinase (PI3K) inhibition has emerged as a novel targeted mechanism for achieving durable remission in CLL in both the untreated and relapsed/refractory setting. Despite this profound efficacy, PI3K inhibition with the delta isoform inhibitor,… read more here.
Keywords: cell populations; toxicity patients; toxicity; high toxicity ... See more keywords
Immunotherapy toxicity in patients over 65 years.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.12027
Abstract: 12027 Background: Cancer patients increasingly present an advanced age at diagnosis; 50% of the new cases are over 65 years old, being underrepresented in clinical trials. The safety of immunotherapy has not been adequately evaluated… read more here.
Keywords: immunotherapy toxicity; toxicity; patients years; oncology ... See more keywords